Abeona Therapeutics Company
Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.
Headquarters:
New York, New York, United States
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Technology:
Others
Founded Date:
1989
Industry:
Gene Therapy